Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 5/20 | 0.54 |
| ▸ | THRB | P10828 | 1/20 | 0.54 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.53 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | LDHA | P00338 | 1/20 | 0.48 |
| ▸ | ERN1 | O75460 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | PAK1 | Q13153 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30714893 | 1.00 | ABCG2 (0.54) | ABCG2THRBNCEH1PTPN22ALDH1A1 | |
| SCHEMBL975681 | 0.84 | NCEH1 (0.53) | NCEH1ALDH1A1HPGDKDM4EMAPT | |
| SCHEMBL4139654 | 0.83 | ABCG2 (0.57) | ABCG2PTPN22ALDH1A1HPGDKDM4E | |
| SCHEMBL4268 | 0.82 | ALDH1A1 (0.61) | ABCG2THRBPTPN22ALDH1A1HPGD | |
| SCHEMBL29593799 | 0.82 | ALDH1A1 (0.61) | ABCG2THRBPTPN22ALDH1A1HPGD | |
| SCHEMBL16784688 | 0.82 | PTPN22 (0.54) | ABCG2PTPN22ALDH1A1HPGDKDM4E | |
| SCHEMBL29376732 | 0.82 | ALDH1A1 (0.61) | ABCG2THRBPTPN22ALDH1A1HPGD | |
| SCHEMBL2907054 | 0.80 | ABCG2 (0.51) | ABCG2PTPN22ALDH1A1HPGDKDM4E | |
| SCHEMBL23079082 | 0.80 | ABCG2 (0.54) | ABCG2PTPN22ALDH1A1HPGDKDM4E | |
| Water SCHEMBL8971546 | 0.80 | ALDH1A1 (0.59) | ABCG2THRBPTPN22ALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2353656-B1 | Functional fragrance precursor | COLGATE PALMOLIVE CO (US) | 2016-06-01 | — | — | EP | claimed |
| EP-2353652-B1 | Functional fragrance precursor | COLGATE PALMOLIVE CO (US) | 2015-07-08 | — | — | EP | claimed |
| EP-2353654-B1 | Functional fragrance precursor | COLGATE PALMOLIVE CO (US) | 2015-06-17 | — | — | EP | claimed |
| US-8906843-B2 | Functional fragrance precursor | COLGATE-PALMOLIVE COMPANY (US) | 2014-12-09 | — | — | US | claimed |
| US-8901068-B2 | Functional fragrance precursor | COLGATE-PALMOLIVE COMPANY (US) | 2014-12-02 | — | — | US | claimed |
| US-8895495-B2 | Functional fragrance precursor | COLGATE-PALMOLIVE COMPANY (US) | 2014-11-25 | — | — | US | claimed |
| US-8895496-B2 | Functional fragrance precursor | COLGATE-PALMOLIVE COMPANY (US) | 2014-11-25 | — | — | US | claimed |
| EP-1567122-B1 | FUNCTIONAL FRAGRANCE PRECURSOR | COLGATE PALMOLIVE CO (US) | 2014-09-17 | — | — | EP | claimed |
| US-20140065081-A1 | FUNCTIONAL FRAGRANCE PRECURSOR | COLGATE-PALMOLIVE COMPANY (US) | 2014-03-06 | — | — | US | claimed |
| US-20140056825-A1 | FUNCTIONAL FRAGRANCE PRECURSOR | COLGATE-PALMOLIVE COMPANY (US) | 2014-02-27 | — | — | US | claimed |
| EP-1143924-B2 | EXOTHERMIC EFFERVESCENT COMPOSITION FOR IMPROVED FRAGRANCE DISPERSION | PHYZZ INC (US) | 2008-11-26 | — | — | EP | claimed |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | BIODERM RESEARCH (US) | 2008-10-16 | — | — | US | claimed |
| WO-2007134666-A1 | FRAGRANCE PRECURSOR | KAO CORPORATION S.A. (ES) | 2007-11-29 | — | — | WO | claimed |
| EP-1857436-A1 | Fragrance precursor | KAO CORPORATION, S.A. (ES) | 2007-11-21 | — | — | EP | claimed |
| US-20060074108-A1 | Matrix metalloprotease (MMP) inhibitors and their application in cosmetic and pharmaceutical composition | BIODERM RESEARCH (US) | 2006-04-06 | — | — | US | claimed |
| EP-1143924-B1 | EXOTHERMIC EFFERVESCENT COMPOSITION FOR IMPROVED FRAGRANCE DISPERSION | PHYZZ INC (US) | 2005-10-26 | — | — | EP | claimed |
| EP-1567122-A2 | FUNCTIONAL FRAGRANCE PRECURSOR | Colgate-Palmolive Company (US) | 2005-08-31 | — | — | EP | claimed |
| EP-1363678-B1 | COMPOSITION FOR AROMA DELIVERY WITH IMPROVED STABILITY AND REDUCED FOAMING | PROCTER & GAMBLE (US) | 2005-05-18 | — | — | EP | claimed |
| WO-2004047788-A2 | FUNCTIONAL FRAGRANCE PRECURSOR | COLGATE-PALMOLIVE COMPANY (US) | 2004-06-10 | — | — | WO | claimed |
| US-20040102357-A1 | For sustained release; fabric softeners, hair conditioners, skin conditioners | COLGATE-PALMOLIVE COMPANY | 2004-05-27 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040102357-A1 | For sustained release; fabric softeners, hair conditioners, skin conditioners | CUTA, APEH, SUCLG1 | ABCG2 1165/4885THRB 2984/4885NCEH1 244/4885 |
| US-20080254130-A1 | Skin Antiaging & Brightening via Multi-function Treatment of Enzyme Dysfunction | PSMB1, PLOD3, CUTA | ABCG2 4406/4885THRB 3874/4885NCEH1 1564/4885 |
| US-20140056825-A1 | FUNCTIONAL FRAGRANCE PRECURSOR | C1R, CUTA, GFER | ABCG2 1200/4885THRB 2906/4885NCEH1 712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.